+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neonatal Intensive Care Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 363 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713019
The global neonatal intensive care market was valued at $2,012.4 million in 2021, and is projected to reach $4,403.0 million by 2031, registering a CAGR of 8.2% from 2022 to 2031.

A neonatal intensive care unit (NICU), also known as an intensive care nursery, is an intensive care unit that specializes in care of ill or premature newborn infants. The common equipment in a neonatal intensive care unit (NICU) include mechanical ventilators to assist breathing through an endotracheal tube or a tracheostomy tube; cardiac monitors for monitoring cardiac condition; equipment for constant monitoring of bodily functions; and a web of intravenous lines, feeding tubes, nasogastric tubes, and suction pumps.

Increase in birth rate and rise in number of preterm births boost growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, around 3,613,647 newborns were reported. Thus, increase in number of child birth and growth in number of preterm births drive growth of the market.

In addition, increase in incidences of maternity factors such as age of mother, alcoholism, and smoking is responsible for low growth rate and preterm delivery of baby, which further contributes toward growth of the market. Age-related factors such as being younger than 16 and older than age 40 contributes toward rise in underdeveloped child delivery rate. However, the rate of child marriage is slowly falling, owing to increase in awareness about child marriages and strict government initiatives. For instance, according to the United Nations Population Fund (UNFPA), in 2021, one in five women between the ages of 20 and 24 reported they had been married as children. From the same source, the total number of child marriages is projected to increase by 2030, owing to regional and socioeconomic factors.

Furthermore, increase in prevalence of chronic diseases such as diabetes and hypertension contribute toward growth of the market. Diabetes during pregnancy may be associated with a high rate of congenital anomalies, disturbances of intrauterine growth, and often post-natal neurobehavioral abnormalities in offspring. The latter are associated with pregestational (PGD) as well as with gestational diabetes (GD). This associated diseases in newborn may require special attention and admission in neonatal intensive care. For instance, according to the International Diabetes Federation (IDF), In 2021, approximately 537 million adults (20-79 years) were living with diabetes. and the number is projected to rise to 643 million by 2030 and 783 million by 2045.

Moreover, increase in R&D activities for development of advanced neonatal intensive cares such as advanced thermometer & oximeters, rise approvals from the in U.S. Food and Drug administration (USFDA), and novel product launches by key players boost the market growth. For instance, in December 2021, , U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Medtronic plc., a global leader in healthcare technology, for its INVOS 7100 cerebral/somatic oximetry system for children from birth through age 18. Furthermore, growing risk of COVID-19 infections in children propels demand for respiratory devices. However, high cost of neonatal intensive care and product recall hinder growth of the market.

The neonatal intensive care market is segmented on the basis of product, application, end user, and region. By product, the market is classified into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The incubators segment is further divided into hybrid incubator, normal incubator, and transport incubator.

Depending on application the market is classified into neonatal hypothermia & low birth weight, jaundice, and others. By end user, it is categorized into hospitals, maternity hospitals, and neonatal & pediatric hospitals. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Drägerwerk AG & Co. KGaA, GE Company, Masimo Corporation, 3M Company, Phoenix Medical Systems Pvt Ltd., Medtronic PLC, Koninklijke Philips N.V, Fanem Medical Devices, Atom Medica, Mediprema Group, Siemens Healthcare GmbH, Terumo Corporation, Medicor Elektronika, Ningbo David Medical Device Co., Ltd., Zhengzhou Dison Instrument and Meter Co., Ltd, AngioDynamics, and Vygon (UK) Ltd.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neonatal intensive care market analysis from 2021 to 2031 to identify the prevailing neonatal intensive care market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the neonatal intensive care market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global neonatal intensive care market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Warmers
  • Incubators
  • Type
  • Hybrid Incubator
  • Normal Incubator
  • Transport Incubator
  • Monitoring Devices
  • Respiratory Devices
  • Phototherapy Equipment
  • Others

By Application

  • Neonatal Hypothermia Low Birth Weight
  • Jaundice
  • Others

By End User

  • Hospitals
  • Maternity Hospitals
  • Neonatal Pediatric Hospital

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Germany
  • France
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Drägerwerk AG & Co. KGaA
  • GE Company
  • Masimo Corporation
  • 3M Company
  • Phoenix Medical Systems Pvt Ltd.
  • Medtronic PLC
  • Koninklijke Philips N.V
  • Fanem Medical Devices
  • Atom Medica
  • Mediprema Group
  • Siemens Healthcare GmbH
  • Terumo Corporation
  • Medicor Elektronika
  • Ningbo David Medical Device Co., Ltd.
  • Zhengzhou Dison Instrument And Meter Co., Ltd
  • AngioDynamics
  • Vygon (UK) Ltd
Frequently Asked Questions about the Global Neonatal Intensive Care Market

What is the estimated value of the Global Neonatal Intensive Care Market?

The Global Neonatal Intensive Care Market was estimated to be valued at $2012.4 million in 2021.

What is the growth rate of the Global Neonatal Intensive Care Market?

The growth rate of the Global Neonatal Intensive Care Market is 8.1%, with an estimated value of $4403 million by 2031.

What is the forecasted size of the Global Neonatal Intensive Care Market?

The Global Neonatal Intensive Care Market is estimated to be worth $4403 million by 2031.

Who are the key companies in the Global Neonatal Intensive Care Market?

Key companies in the Global Neonatal Intensive Care Market include Drägerwerk AG & Co. KGaA, GE Company, Masimo Corporation, 3M Company, Phoenix Medical Systems Pvt Ltd., Medtronic PLC, Koninklijke Philips N.V, Fanem Medical Devices and Mediprema Group.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: NEONATAL INTENSIVE CARE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Warmers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Incubators
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Incubators Neonatal Intensive Care Market by Type
4.3.4.1 Hybrid Incubator Market size and forecast, by region
4.3.4.2 Normal Incubator Market size and forecast, by region
4.3.4.3 Transport Incubator Market size and forecast, by region
4.4 Monitoring Devices
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Respiratory Devices
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Phototherapy Equipment
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country

CHAPTER 5: NEONATAL INTENSIVE CARE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Neonatal Hypothermia & Low Birth Weight
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Jaundice
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: NEONATAL INTENSIVE CARE MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Maternity Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Neonatal & Pediatric Hospital
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: NEONATAL INTENSIVE CARE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Incubators Neonatal Intensive Care Market by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Incubators Neonatal Intensive Care Market by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Incubators Neonatal Intensive Care Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Incubators Neonatal Intensive Care Market by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Drägerwerk AG & Co. KGaA
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 GE Company
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Masimo Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 3M Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Phoenix Medical Systems Pvt Ltd.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Medtronic PLC
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Koninklijke Philips N. V
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Fanem Medical Devices
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Atom Medica
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Mediprema Group
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Siemens Healthcare GmbH
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Terumo Corporation
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Medicor Elektronika
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Ningbo David Medical Device Co., Ltd.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Zhengzhou Dison Instrument And Meter Co., Ltd
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 AngioDynamics
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Vygon (UK) Ltd
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments

List of Tables
Table 1. Global Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 2. Neonatal Intensive Care Market Size, for Warmers, by Region, 2021-2031 ($Million)
Table 3. Neonatal Intensive Care Market for Warmers, by Country, 2021-2031 ($Million)
Table 4. Neonatal Intensive Care Market Size, for Incubators, by Region, 2021-2031 ($Million)
Table 5. Neonatal Intensive Care Market for Incubators, by Country, 2021-2031 ($Million)
Table 6. Global Incubators Neonatal Intensive Care Market, by Type, 2021-2031 ($Million)
Table 7. Neonatal Intensive Care Market, for Hybrid Incubator, by Region, 2021-2031 ($Million)
Table 8. Neonatal Intensive Care Market, for Normal Incubator, by Region, 2021-2031 ($Million)
Table 9. Neonatal Intensive Care Market, for Transport Incubator, by Region, 2021-2031 ($Million)
Table 10. Neonatal Intensive Care Market Size, for Monitoring Devices, by Region, 2021-2031 ($Million)
Table 11. Neonatal Intensive Care Market for Monitoring Devices, by Country, 2021-2031 ($Million)
Table 12. Neonatal Intensive Care Market Size, for Respiratory Devices, by Region, 2021-2031 ($Million)
Table 13. Neonatal Intensive Care Market for Respiratory Devices, by Country, 2021-2031 ($Million)
Table 14. Neonatal Intensive Care Market Size, for Phototherapy Equipment, by Region, 2021-2031 ($Million)
Table 15. Neonatal Intensive Care Market for Phototherapy Equipment, by Country, 2021-2031 ($Million)
Table 16. Neonatal Intensive Care Market Size, for Others, by Region, 2021-2031 ($Million)
Table 17. Neonatal Intensive Care Market for Others, by Country, 2021-2031 ($Million)
Table 18. Global Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 19. Neonatal Intensive Care Market Size, for Neonatal Hypothermia & Low Birth Weight, by Region, 2021-2031 ($Million)
Table 20. Neonatal Intensive Care Market for Neonatal Hypothermia & Low Birth Weight, by Country, 2021-2031 ($Million)
Table 21. Neonatal Intensive Care Market Size, for Jaundice, by Region, 2021-2031 ($Million)
Table 22. Neonatal Intensive Care Market for Jaundice, by Country, 2021-2031 ($Million)
Table 23. Neonatal Intensive Care Market Size, for Others, by Region, 2021-2031 ($Million)
Table 24. Neonatal Intensive Care Market for Others, by Country, 2021-2031 ($Million)
Table 25. Global Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 26. Neonatal Intensive Care Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 27. Neonatal Intensive Care Market for Hospitals, by Country, 2021-2031 ($Million)
Table 28. Neonatal Intensive Care Market Size, for Maternity Hospitals, by Region, 2021-2031 ($Million)
Table 29. Neonatal Intensive Care Market for Maternity Hospitals, by Country, 2021-2031 ($Million)
Table 30. Neonatal Intensive Care Market Size, for Neonatal & Pediatric Hospital, by Region, 2021-2031 ($Million)
Table 31. Neonatal Intensive Care Market for Neonatal & Pediatric Hospital, by Country, 2021-2031 ($Million)
Table 32. Neonatal Intensive Care Market, by Region, 2021-2031 ($Million)
Table 33. North America Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 34. North America Incubators Neonatal Intensive Care Market, by Type, 2021-2031 ($Million)
Table 35. North America Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 36. North America Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 37. North America Neonatal Intensive Care Market, by Country, 2021-2031 ($Million)
Table 38. U.S. Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 39. U.S. Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 40. U.S. Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 41. Canada Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 42. Canada Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 43. Canada Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 44. Mexico Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 45. Mexico Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 46. Mexico Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 47. Europe Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 48. Europe Incubators Neonatal Intensive Care Market, by Type, 2021-2031 ($Million)
Table 49. Europe Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 50. Europe Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 51. Europe Neonatal Intensive Care Market, by Country, 2021-2031 ($Million)
Table 52. Germany Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 53. Germany Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 54. Germany Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 55. France Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 56. France Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 57. France Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 58. UK Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 59. UK Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 60. UK Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 61. Italy Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 62. Italy Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 63. Italy Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 64. Spain Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 65. Spain Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 66. Spain Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 67. Rest of Europe Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 68. Rest of Europe Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 69. Rest of Europe Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 70. Asia-Pacific Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 71. Asia-Pacific Incubators Neonatal Intensive Care Market, by Type, 2021-2031 ($Million)
Table 72. Asia-Pacific Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 73. Asia-Pacific Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 74. Asia-Pacific Neonatal Intensive Care Market, by Country, 2021-2031 ($Million)
Table 75. China Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 76. China Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 77. China Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 78. Japan Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 79. Japan Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 80. Japan Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 81. India Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 82. India Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 83. India Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 84. Australia Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 85. Australia Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 86. Australia Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 87. South Korea Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 88. South Korea Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 89. South Korea Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 90. Rest of Asia-Pacific Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 91. Rest of Asia-Pacific Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 92. Rest of Asia-Pacific Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 93. LAMEA Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 94. LAMEA Incubators Neonatal Intensive Care Market, by Type, 2021-2031 ($Million)
Table 95. LAMEA Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 96. LAMEA Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 97. LAMEA Neonatal Intensive Care Market, by Country, 2021-2031 ($Million)
Table 98. Brazil Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 99. Brazil Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 100. Brazil Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 101. Saudi Arabia Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 102. Saudi Arabia Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 103. Saudi Arabia Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 104. South Africa Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 105. South Africa Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 106. South Africa Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 107. Rest of LAMEA Neonatal Intensive Care Market, by Product, 2021-2031 ($Million)
Table 108. Rest of LAMEA Neonatal Intensive Care Market, by Application, 2021-2031 ($Million)
Table 109. Rest of LAMEA Neonatal Intensive Care Market, by End-user, 2021-2031 ($Million)
Table 110. Drägerwerk AG & Co. KGaA: Company Snapshot
Table 111. Drägerwerk AG & Co. KGaA: Operating Segments
Table 112. Drägerwerk AG & Co. KGaA: Product Portfolio
Table 113. Drägerwerk AG & Co. KGaA: Net Sales
Table 114. Drägerwerk AG & Co. KGaA: Key Strategies
Table 115. GE Company: Company Snapshot
Table 116. GE Company: Operating Segments
Table 117. GE Company: Product Portfolio
Table 118. GE Company: Net Sales
Table 119. GE Company: Key Strategies
Table 120. Masimo Corporation: Company Snapshot
Table 121. Masimo Corporation: Operating Segments
Table 122. Masimo Corporation: Product Portfolio
Table 123. Masimo Corporation: Net Sales
Table 124. Masimo Corporation: Key Strategies
Table 125. 3M Company: Company Snapshot
Table 126. 3M Company: Operating Segments
Table 127. 3M Company: Product Portfolio
Table 128. 3M Company: Net Sales
Table 129. 3M Company: Key Strategies
Table 130. Phoenix Medical Systems Pvt Ltd.: Company Snapshot
Table 131. Phoenix Medical Systems Pvt Ltd.: Operating Segments
Table 132. Phoenix Medical Systems Pvt Ltd.: Product Portfolio
Table 133. Phoenix Medical Systems Pvt Ltd.: Net Sales
Table 134. Phoenix Medical Systems Pvt Ltd.: Key Strategies
Table 135. Medtronic PLC: Company Snapshot
Table 136. Medtronic PLC: Operating Segments
Table 137. Medtronic PLC: Product Portfolio
Table 138. Medtronic PLC: Net Sales
Table 139. Medtronic PLC: Key Strategies
Table 140. Koninklijke Philips N. V: Company Snapshot
Table 141. Koninklijke Philips N. V: Operating Segments
Table 142. Koninklijke Philips N. V: Product Portfolio
Table 143. Koninklijke Philips N. V: Net Sales
Table 144. Koninklijke Philips N. V: Key Strategies
Table 145. Fanem Medical Devices: Company Snapshot
Table 146. Fanem Medical Devices: Operating Segments
Table 147. Fanem Medical Devices: Product Portfolio
Table 148. Fanem Medical Devices: Net Sales
Table 149. Fanem Medical Devices: Key Strategies
Table 150. Atom Medica: Company Snapshot
Table 151. Atom Medica: Operating Segments
Table 152. Atom Medica: Product Portfolio
Table 153. Atom Medica: Net Sales
Table 154. Atom Medica: Key Strategies
Table 155. Mediprema Group: Company Snapshot
Table 156. Mediprema Group: Operating Segments
Table 157. Mediprema Group: Product Portfolio
Table 158. Mediprema Group: Net Sales
Table 159. Mediprema Group: Key Strategies
Table 160. Siemens Healthcare GmbH: Company Snapshot
Table 161. Siemens Healthcare GmbH: Operating Segments
Table 162. Siemens Healthcare GmbH: Product Portfolio
Table 163. Siemens Healthcare GmbH: Net Sales
Table 164. Siemens Healthcare GmbH: Key Strategies
Table 165. Terumo Corporation: Company Snapshot
Table 166. Terumo Corporation: Operating Segments
Table 167. Terumo Corporation: Product Portfolio
Table 168. Terumo Corporation: Net Sales
Table 169. Terumo Corporation: Key Strategies
Table 170. Medicor Elektronika: Company Snapshot
Table 171. Medicor Elektronika: Operating Segments
Table 172. Medicor Elektronika: Product Portfolio
Table 173. Medicor Elektronika: Net Sales
Table 174. Medicor Elektronika: Key Strategies
Table 175. Ningbo David Medical Device Co. Ltd.: Company Snapshot
Table 176. Ningbo David Medical Device Co. Ltd.: Operating Segments
Table 177. Ningbo David Medical Device Co. Ltd.: Product Portfolio
Table 178. Ningbo David Medical Device Co. Ltd.: Net Sales
Table 179. Ningbo David Medical Device Co. Ltd.: Key Strategies
Table 180. Zhengzhou Dison Instrument and Meter Co. Ltd.: Company Snapshot
Table 181. Zhengzhou Dison Instrument and Meter Co. Ltd.: Operating Segments
Table 182. Zhengzhou Dison Instrument and Meter Co. Ltd.: Product Portfolio
Table 183. Zhengzhou Dison Instrument and Meter Co. Ltd.: Net Sales
Table 184. Zhengzhou Dison Instrument and Meter Co. Ltd.: Key Strategies
Table 185. Angiodynamics: Company Snapshot
Table 186. Angiodynamics: Operating Segments
Table 187. Angiodynamics: Product Portfolio
Table 188. Angiodynamics: Net Sales
Table 189. Angiodynamics: Key Strategies
Table 190. Vygon (Uk) Ltd.: Company Snapshot
Table 191. Vygon (Uk) Ltd.: Operating Segments
Table 192. Vygon (Uk) Ltd.: Product Portfolio
Table 193. Vygon (Uk) Ltd.: Net Sales
Table 194. Vygon (Uk) Ltd.: Key Strategies

List of Figures
Figure 1. Neonatal Intensive Care Market Segmentation
Figure 2. Neonatal Intensive Care Market, 2021-2031
Figure 3. Neonatal Intensive Care Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Neonatal Intensive Care Mark.:Drivers, Restraints and Opportunities
Figure 12. Neonatal Intensive Care Market, By Product, 2021(%)
Figure 13. Comparative Share Analysis of Warmers Neonatal Intensive Care Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Incubators Neonatal Intensive Care Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Monitoring Devices Neonatal Intensive Care Market, 2021-2031(%)
Figure 16. Comparative Share Analysis of Respiratory Devices Neonatal Intensive Care Market, 2021-2031(%)
Figure 17. Comparative Share Analysis of Phototherapy Equipment Neonatal Intensive Care Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Others Neonatal Intensive Care Market, 2021-2031(%)
Figure 19. Neonatal Intensive Care Market, By Application, 2021(%)
Figure 20. Comparative Share Analysis of Neonatal Hypothermia & Low Birth Weight Neonatal Intensive Care Market, 2021-2031(%)
Figure 21. Comparative Share Analysis of Jaundice Neonatal Intensive Care Market, 2021-2031(%)
Figure 22. Comparative Share Analysis of Others Neonatal Intensive Care Market, 2021-2031(%)
Figure 23. Neonatal Intensive Care Market, By End-user, 2021(%)
Figure 24. Comparative Share Analysis of Hospitals Neonatal Intensive Care Market, 2021-2031(%)
Figure 25. Comparative Share Analysis of Maternity Hospitals Neonatal Intensive Care Market, 2021-2031(%)
Figure 26. Comparative Share Analysis of Neonatal & Pediatric Hospital Neonatal Intensive Care Market, 2021-2031(%)
Figure 27. Neonatal Intensive Care Market by Region, 2021
Figure 28. U.S. Neonatal Intensive Care Market, 2021-2031($Million)
Figure 29. Canada Neonatal Intensive Care Market, 2021-2031($Million)
Figure 30. Mexico Neonatal Intensive Care Market, 2021-2031($Million)
Figure 31. Germany Neonatal Intensive Care Market, 2021-2031($Million)
Figure 32. France Neonatal Intensive Care Market, 2021-2031($Million)
Figure 33. Uk Neonatal Intensive Care Market, 2021-2031($Million)
Figure 34. Italy Neonatal Intensive Care Market, 2021-2031($Million)
Figure 35. Spain Neonatal Intensive Care Market, 2021-2031($Million)
Figure 36. Rest of Europe Neonatal Intensive Care Market, 2021-2031($Million)
Figure 37. China Neonatal Intensive Care Market, 2021-2031($Million)
Figure 38. Japan Neonatal Intensive Care Market, 2021-2031($Million)
Figure 39. India Neonatal Intensive Care Market, 2021-2031($Million)
Figure 40. Australia Neonatal Intensive Care Market, 2021-2031($Million)
Figure 41. South Korea Neonatal Intensive Care Market, 2021-2031($Million)
Figure 42. Rest of Asia-Pacific Neonatal Intensive Care Market, 2021-2031($Million)
Figure 43. Brazil Neonatal Intensive Care Market, 2021-2031($Million)
Figure 44. Saudi Arabia Neonatal Intensive Care Market, 2021-2031($Million)
Figure 45. South Africa Neonatal Intensive Care Market, 2021-2031($Million)
Figure 46. Rest of LAMEA Neonatal Intensive Care Market, 2021-2031($Million)
Figure 47. Top Winning Strategies, by Year
Figure 48. Top Winning Strategies, by Development
Figure 49. Top Winning Strategies, by Company
Figure 50. Product Mapping of Top 10 Players
Figure 51. Competitive Dashboard
Figure 52. Competitive Heatmap of Top 10 Key Players
Figure 53. Drägerwerk AG & Co. Kga.: Net Sales, ($Million)
Figure 54. Ge Compan.: Net Sales, ($Million)
Figure 55. Masimo Corporatio.: Net Sales, ($Million)
Figure 56. 3M Compan.: Net Sales, ($Million)
Figure 57. Phoenix Medical Systems Pvt Ltd.: Net Sales, ($Million)
Figure 58. Medtronic pl.: Net Sales, ($Million)
Figure 59. Koninklijke Philips N..: Net Sales, ($Million)
Figure 60. Fanem Medical Device.: Net Sales, ($Million)
Figure 61. Atom Medic.: Net Sales, ($Million)
Figure 62. Mediprema Grou.: Net Sales, ($Million)
Figure 63. Siemens Healthcare Gmb.: Net Sales, ($Million)
Figure 64. Terumo Corporatio.: Net Sales, ($Million)
Figure 65. Medicor Elektronik.: Net Sales, ($Million)
Figure 66. Ningbo David Medical Device Co. Ltd.: Net Sales, ($Million)
Figure 67. Zhengzhou Dison Instrument and Meter Co. Lt.: Net Sales, ($Million)
Figure 68. Angiodynamic.: Net Sales, ($Million)
Figure 69. Vygon (Uk) Lt.: Net Sales, ($Million)

Executive Summary

According to the report, “Neonatal Intensive Care Market," the neonatal intensive care market was valued at $2.0 billion in 2021, and is estimated to reach $4.4 billion by 2031, growing at a CAGR of 8.2% from 2022 to 2031.

The neonatal intensive care unit is a particular section of a hospital where newborn infants who require intensive medical care are often admitted. a neonatal intensive care unit (NICU) is equipped with advanced equipment and skilled medical staff to provide specialized treatment for children.

Growth in incidences of newborn diseases and complications such as underweight babies, overweight babies, birth defects, and respiratory distress, which require special attention and admission in NICUs drive the growth of the market. For instance, in 2020, according to Myspace, a global platform for physicians and healthcare professionals, in the U.S. respiratory distress syndrome has been estimated to occur in 20,000-30,000 newborn infants each year.

Furthermore, Neonatal Intensive Care Market trends that drive the growth of the neonatal intensive care market include R&D for the development of neonatal intensive care, an increase in product approvals, and new product launches in the market. For instance, Medtronic plc, the global leader in medical technology, announced the U.S. commercial launch of the SonarMed airway monitoring system. The first and only device of its kind, the SonarMed airway monitoring system utilizes acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for infants and pediatrics.

In addition, the rise in concerns regarding neonatal care and a rise in pregnancy rate further contributes to the growth of the market. Furthermore, the rise in healthcare expenditure and improvements in healthcare facilities in developing nations contributes to the growth of the Neonatal Intensive Care Market growth.

Moreover, government initiatives to provide advanced health care facilities at lower cost contributes in the growth of the Neonatal Intensive Care Industry. In addition, an increase in the number of private hospitals and a rise in demand for advanced neonatal intensive care facilities boost the Neonatal Intensive Care Market size.

The neonatal intensive care market is segmented on the basis of product, application, end user, and region.

On the basis of product, the market is divided into warmers, incubators, monitoring devices, respiratory devices, phototherapy equipment, and others. The respiratory device segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to the growing risk of COVID-19 and the rise in the prevalence of pneumonia. However, the incubators segment is expected to witness considerable growth during the forecast period, due to an increase in incubators installation and rise in incidence of underweight infant birth.

By application, the market is categorized into neonatal hypothermia & low birth weight, jaundice, and others. The neonatal hypothermia & low birth weight segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in incidences of preterm child births and advancements in neonatal intensive care unit (NICU) equipment. However, the jaundice segment is expected to witness considerable growth during the forecast period, due to increase in incidence of neonatal jaundice and advancements in infant jaundice.

By end user, the market is classified into hospitals, maternity hospitals, and neonatal & pediatric hospitals. The neonatal & pediatric hospitals segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in healthcare expenditure and rise in number of neonatal & pediatric hospitals. However, the hospital segment is expected to witness considerable growth during the forecast period, due to increase in number of hospitals and rise in healthcare expenditures.

Asia-Pacific accounted for a majority of the global neonatal intensive care market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of infant jaundice, high birth rate, and presence of key players in the region. Europe is anticipated to witness lucrative growth, owing to increase in incidences of preterm child birth and growing healthcare expenditure.

Key Findings of the Study

  • On the basis of product, the respiratory device segment was the highest contributor to the market in 2021.
  • By application, the neonatal hypothermia & low birth weight segment was the highest contributor to the market in 2021.
  • Depending on end user, the neonatal & pediatric hospital segment was the highest contributor to the market in 2021.
  • Region wise, Asia-Pacific garnered the largest revenue share in 2021, whereas Europe is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

  • Drägerwerk AG & Co. KGaA
  • GE Company
  • Masimo Corporation
  • 3M Company
  • Phoenix Medical Systems Pvt Ltd.
  • Medtronic PLC
  • Koninklijke Philips N.V
  • Fanem Medical Devices
  • Atom Medica
  • Mediprema Group
  • Siemens Healthcare GmbH
  • Terumo Corporation
  • Medicor Elektronika
  • Ningbo David Medical Device Co., Ltd.
  • Zhengzhou Dison Instrument And Meter Co., Ltd
  • AngioDynamics
  • Vygon (UK) Ltd

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...